nodes	percent_of_prediction	percent_of_DWPC	metapath
Enprofylline—PDE4A—DARPP-32 events—PRKACA—adrenal gland cancer	0.0427	0.0427	CbGpPWpGaD
Enprofylline—PDE4B—DARPP-32 events—PRKACA—adrenal gland cancer	0.0395	0.0395	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0386	0.0386	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0298	0.0298	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Other—GNRHR—adrenal gland cancer	0.0295	0.0295	CbGpPWpGaD
Enprofylline—ADORA2B—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0188	0.0188	CbGpPWpGaD
Enprofylline—PDE4A—Opioid Signalling—PRKACA—adrenal gland cancer	0.0172	0.0172	CbGpPWpGaD
Enprofylline—PDE4A—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.017	0.017	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0168	0.0168	CbGpPWpGaD
Enprofylline—PDE4B—Opioid Signalling—PRKACA—adrenal gland cancer	0.0159	0.0159	CbGpPWpGaD
Enprofylline—PDE4B—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0158	0.0158	CbGpPWpGaD
Enprofylline—PDE4A—G Protein Signaling Pathways—PRKACA—adrenal gland cancer	0.0154	0.0154	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0142	0.0142	CbGpPWpGaD
Enprofylline—PDE4B—G Protein Signaling Pathways—PRKACA—adrenal gland cancer	0.0142	0.0142	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0128	0.0128	CbGpPWpGaD
Enprofylline—PDE4A—G Protein Signaling Pathways—GNAS—adrenal gland cancer	0.0125	0.0125	CbGpPWpGaD
Enprofylline—ADORA2A—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0123	0.0123	CbGpPWpGaD
Enprofylline—PDE4B—G Protein Signaling Pathways—GNAS—adrenal gland cancer	0.0115	0.0115	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.011	0.011	CbGpPWpGaD
Enprofylline—ADORA2B—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.0109	0.0109	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0108	0.0108	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.01	0.01	CbGpPWpGaD
Enprofylline—PDE4A—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00991	0.00991	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—PRKACA—adrenal gland cancer	0.00946	0.00946	CbGpPWpGaD
Enprofylline—PDE4A—Opioid Signalling—POMC—adrenal gland cancer	0.00938	0.00938	CbGpPWpGaD
Enprofylline—PDE4B—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00917	0.00917	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00894	0.00894	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00884	0.00884	CbGpPWpGaD
Enprofylline—PDE4B—Opioid Signalling—POMC—adrenal gland cancer	0.00868	0.00868	CbGpPWpGaD
Enprofylline—ADORA2B—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.00856	0.00856	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00853	0.00853	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00837	0.00837	CbGpPWpGaD
Enprofylline—ADORA2B—C-MYB transcription factor network—PTGS2—adrenal gland cancer	0.008	0.008	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—GNAS—adrenal gland cancer	0.00767	0.00767	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00764	0.00764	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00761	0.00761	CbGpPWpGaD
Enprofylline—ADORA2B—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00735	0.00735	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00721	0.00721	CbGpPWpGaD
Enprofylline—ADORA2A—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00716	0.00716	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00682	0.00682	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00681	0.00681	CbGpPWpGaD
Enprofylline—PDE4A—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00667	0.00667	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00659	0.00659	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00655	0.00655	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00655	0.00655	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0065	0.0065	CbGpPWpGaD
Enprofylline—PDE4B—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00617	0.00617	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00613	0.00613	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00606	0.00606	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00594	0.00594	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.00589	0.00589	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00587	0.00587	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00579	0.00579	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00557	0.00557	CbGpPWpGaD
Enprofylline—ADORA1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00556	0.00556	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0055	0.0055	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00502	0.00502	CbGpPWpGaD
Enprofylline—ADORA2A—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00482	0.00482	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00473	0.00473	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—PRKACA—adrenal gland cancer	0.00453	0.00453	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00447	0.00447	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00432	0.00432	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0043	0.0043	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00396	0.00396	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00392	0.00392	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00392	0.00392	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00387	0.00387	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00385	0.00385	CbGpPWpGaD
Enprofylline—ADORA1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00375	0.00375	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00367	0.00367	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00363	0.00363	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0036	0.0036	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00356	0.00356	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00351	0.00351	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0035	0.0035	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—TSHR—adrenal gland cancer	0.0035	0.0035	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0035	0.0035	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.00349	0.00349	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00338	0.00338	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00337	0.00337	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00333	0.00333	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0033	0.0033	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00329	0.00329	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00327	0.00327	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00326	0.00326	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00325	0.00325	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00323	0.00323	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00307	0.00307	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00306	0.00306	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00302	0.00302	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00298	0.00298	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00297	0.00297	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00294	0.00294	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00287	0.00287	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00284	0.00284	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00284	0.00284	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—BAD—adrenal gland cancer	0.00268	0.00268	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—POMC—adrenal gland cancer	0.00267	0.00267	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.0026	0.0026	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00257	0.00257	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00254	0.00254	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00253	0.00253	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00251	0.00251	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—BRAF—adrenal gland cancer	0.00244	0.00244	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00236	0.00236	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00234	0.00234	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00232	0.00232	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0023	0.0023	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00229	0.00229	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00228	0.00228	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—POMC—adrenal gland cancer	0.00227	0.00227	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00224	0.00224	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00222	0.00222	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GNRH1—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.00206	0.00206	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00195	0.00195	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00192	0.00192	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TSHR—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00181	0.00181	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SPRY2—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00179	0.00179	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MEN1—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TSHR—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TSHR—adrenal gland cancer	0.00173	0.00173	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00173	0.00173	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MEN1—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MEN1—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—TP53—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.00148	0.00148	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00147	0.00147	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—EGFR—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00139	0.00139	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PRKACA—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00133	0.00133	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—POMC—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PRKACA—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—POMC—adrenal gland cancer	0.00124	0.00124	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—POMC—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—POMC—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CDC42—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IGF2—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GNAS—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CDC42—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CDC42—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IGF2—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GNAS—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IGF2—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GNAS—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TERT—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000996	0.000996	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00099	0.00099	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000984	0.000984	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000973	0.000973	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TERT—adrenal gland cancer	0.000916	0.000916	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000899	0.000899	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000877	0.000877	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TERT—adrenal gland cancer	0.000857	0.000857	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TERT—adrenal gland cancer	0.000847	0.000847	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000825	0.000825	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000809	0.000809	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000799	0.000799	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—BAD—adrenal gland cancer	0.000797	0.000797	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000795	0.000795	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000789	0.000789	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000774	0.000774	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000769	0.000769	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—BAD—adrenal gland cancer	0.000746	0.000746	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—BAD—adrenal gland cancer	0.000737	0.000737	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—POMC—adrenal gland cancer	0.000734	0.000734	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—BRAF—adrenal gland cancer	0.000725	0.000725	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000703	0.000703	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—POMC—adrenal gland cancer	0.000688	0.000688	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—POMC—adrenal gland cancer	0.00068	0.00068	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—BRAF—adrenal gland cancer	0.000679	0.000679	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—BRAF—adrenal gland cancer	0.000671	0.000671	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000662	0.000662	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000658	0.000658	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—EGFR—adrenal gland cancer	0.00065	0.00065	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000577	0.000577	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000576	0.000576	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000531	0.000531	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000524	0.000524	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000524	0.000524	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000508	0.000508	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000491	0.000491	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000485	0.000485	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000457	0.000457	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—EGFR—adrenal gland cancer	0.000415	0.000415	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—EGFR—adrenal gland cancer	0.000389	0.000389	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—EGFR—adrenal gland cancer	0.000384	0.000384	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TP53—adrenal gland cancer	0.000384	0.000384	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000379	0.000379	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TP53—adrenal gland cancer	0.000349	0.000349	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TP53—adrenal gland cancer	0.000326	0.000326	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TP53—adrenal gland cancer	0.000323	0.000323	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—EGFR—adrenal gland cancer	0.0003	0.0003	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TP53—adrenal gland cancer	0.000252	0.000252	CbGpPWpGaD
